stockrowSchrodinger, Inc.
SDGR Healthcare Health Information Services
Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.
- Revenue
- +18.7%
- EPS
- −11.1%
- Free cash flow
- +21.6%
Quarter to September 2026, against a year earlier
Follow SDGR
Alert me
Schrodinger, Inc. (SDGR) Return on equity
Schrodinger, Inc.'s return on equity over the twelve months to 30 September 2026 was −19.0%, up 7.3 percentage points from fiscal 2025 (−26.3%). Over the past ten years it has ranged from −38.6% (fiscal 2024) to 48.6% (fiscal 2018); the current reading is higher than 33% of that period. That is below the Health Information Services industry median of −3.15% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | −26.3% | 12.29 |
| FY2024 | −38.6% | (46.75) |
| FY2023 | 8.17% | 37.86 |
| FY2022 | −29.7% | (12.69) |
| FY2021 | −17.0% | (7.78) |
| FY2020 | −9.22% | (39.02) |
| FY2019 | 29.8% | (18.82) |
| FY2018 | 48.6% | 18.87 |
| FY2017 | 29.8% | — |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| HTFL Heartflow, Inc. compare | 38.5% |
| HSTM HealthStream, Inc. compare | 5.45% |
| PRVA Privia Health Group, Inc. compare | 4.25% |
| GDRX GoodRx Holdings, Inc. compare | 2.52% |
| OMDA Omada Health, Inc. compare | 1.84% |
| OMCL Omnicell, Inc. compare | 0.00% |
| CERT Certara, Inc. compare | −6.30% |
| TDOC Teladoc Health, Inc. compare | −11.5% |
| SDGR Schrodinger, Inc. | −19.0% |
| Health Information Services industry median | −3.15% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on SDGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement